CAS No.: | 2381089-83-2 |
---|---|
Formula: | C50h69n15o9 |
EINECS: | 1308068-626-2 |
Type: | Pharmaceutical Intermediates |
Appearance: | Powder |
Quality: | Technical |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Retatrutide is a triple glucagon, GIP, and GLP-1 receptor agonist. Retatrutide showed glucose control
and weight loss in patients with type 2 diabetes mellitus (T2DM).
What Is Retatrutide?
Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned
for its breakthrough in diabetes and obesity treatment.
Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin
(subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes
and obesity compared to the predecessors.
You Get What You Paid For :
2mg | 5mg | 10mg | |
Semaglutide | $80/Box | $140/Box | $270/Box |
Tirzepatide | $90/Box | $155/Box | $280/Box |
Retatrutide | $180/Box | $360/Box | $650/Box |
It's in US Dollar, 10vials per Box. Price is negotiated if order in bulk. Good quality with after-sale
service superior to peers.
For Research Purpose Only.
Purchasing objects are required to be companies and labs, not for personal use.
Suppliers with verified business licenses